SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001044321-14-000097
Filing Date
2014-09-09
Accepted
2014-09-09 16:44:45
Documents
1
Group Members
ADAM C. STETTNERAUSTIN W. MARXEAWM INVESTMENT CO INC.DAVID M. GREENHOUSELS AVIDERS LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.SSCAYMAN LLC

Document Format Files

Seq Description Document Type Size
1 COLLECTAR BIOSCIENCES 13D collectar13dt.txt SC 13D 9128
  Complete submission text file 0001044321-14-000097.txt   11230
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2123196670
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85798 | Film No.: 141093805
SIC: 2834 Pharmaceutical Preparations